Chalmers Ventures AB — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications.
BiotechHealthtechMedical DevicesGothenburg, SE
Anand Kumar Rajasekharan(PhD, CEO & Co-founder)inSaba Atefyekta(PhD, Sales & Marketing Director & Co-founder)inMartin Andersson(PhD, R&D Director & Co-founder)
Co-investorsAlmi Invest
Eneryield builds Eneryield IntelliView®, an AI and physics-informed predictive analytics product that detects grid faults from electrical waveforms for utilities and industrial power systems.
AI & Machine LearningCleantechDeep TechEnergyEnterprise SoftwareGöteborg, SE
Ebrahim Balouji(CEO & Co-founder)inKarl Bäckström(Co-founder)in
Co-investorsTechstars
Vividye develops sustainable pigments and dyes that eliminate harmful chemicals and microplastics from the color production process.
Circular EconomyCleantechDeep TechNew Materials
Johanna Nissén Karlsson(CEO & Co-Founder)inGustav Larsson-Utas(COO & Co-founder)inRomain Bordes(Head of R&D & Co-Founder)
Co-investorsAlmi Invest
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








